HomeREGULATORY
REGULATORY

Post-Transplant Patients Added to Careful Use List for Keytruda Label/Guidelines
(Oct.18.2017)

The Ministry of Health, Labor and Welfare (MHLW) has updated optimal use promotion guidelines for MSD’s anti-PD-1 antibody Keytruda (pembrolizumab), adding patients with a history of organ transplants (including hematopoietic stem cell transplants) to its careful use list ...
(LOG IN FOR FULL STORY)

News Calendar